Asia-Pacific Active Pharmaceutical Ingredient Market Analysis 2012-2017 and Forecast 2018-2023

SKU ID :99ST-11153075 | Published Date: 14-Mar-2018 | No. of pages: 160
Snapshot
Active pharmaceutical ingredients or APIs can be defined as the chemicals used to manufacture pharmaceutical drugs. The active ingredient (AI) is the substance or substances that are biologically active within the drug and is the specific component responsible for the desired effect it has on the individual taking it. API also refers to the active or central ingredient in the product which causes the direct effect on the disease diagnosis, prevention, treatment or cure. While API is the active component of a drug, excipients are the inactive or inert substances present in a drug.
The Asia-Pacific Active Pharmaceutical Ingredient market will reach xxx Million USD in 2018 and CAGR xx% 2018-2023. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Active Pharmaceutical Ingredient by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.
Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
Synthetic API
Biotech API
Others



Company Coverage (Sales Revenue, Price, Gross Margin, Main Products etc.):
Teva
Novartis
Pfizer
Johnson & Johnson
Mylan
North China Pharmaceutical Group
Dr. Reddy’s Laboratories
Roche
Aurobindo pharma
Sun Pharmaceutical Industries
Boehringer Ingelheim GmbH
Bayer
BASF
DSM
Zhejiang Medicine
Biocon
Johnson Matthey
Hisun Pharmacy
Cambrex
Shandong Xinhua Pharmaceutical
Lonza group
Huahai Pharmaceutical
Haerbin Pharmaceutical Group
Cipla
Tian Yao
Lupin
North East Pharmaceutical
Albemarle
Shandong Lukang Pharmaceutical
Jiangsu Hengrui Medicine
Bachem
Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):
Non-steroidal Anti-inflammatory Drugs (NSAIDs)
Oncology Drugs
Anti-diabetic Drugs
Cardiovascular Drugs
Central Nervous System Drugs (CNS Drugs)
Musculoskeletal Drugs
Other Drugs
Region Coverage (Regional Production, Demand & Forecast by Regions etc.):
China
Japan & Korea
India
Southeast Asia
Oceania
  • PRICE
  • $3300
    $6600
    Buy Now

Our Clients